Default company panoramic image

Phoenix Cardiac Devices, Inc.

Next generation medical device to treat mitral regurgitation without open heart surgery and with flexibility to adjust post implantation.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Northbrook, IL, USA
  • Currency USD
  • Founded October 2012
  • Employees 1
  • Website

Company Summary

Mitral Regurgitation affects ~2% of the global population. Current standard of care requires open heart surgery to repair or replace the mitral valve. BACE device does not require open heart surgery because it sits outside of and around the heart. The device can also be adjusted post-op by a cardiologist in an out-patient setting to maintain efficacy. "No open heart surgery" and "post-op adjustability" are the key benefits.


  • Default avatar
    Gopal Muppirala

    Over 30 years of commercial experience in sales, marketing at the local and global levels, market research, new product development, and operations. As the Global Commercial Director at Glaxo, led the transformation of a neurology product from a small contributor ($200MM) to the organization to a blockbuster with over $2B in sales, including new indications and the development of a key line extension, for which he holds a patent.

  • Default avatar
    Jai Raman
    Chief Scientific Officer

    A highly skilled cardio-thoracic surgeon known for his efforts to develop new and innovative surgical procedures, particularly for the treatment of heart failure. He is currently a Professor of Surgery and Director of Adult Cardiac Surgery at Rush University Medical Center in Chicago. Dr. Raman has performed nearly 2,500 heart surgeries and more than 700 thoracic operations during his career.

  • Default avatar
    Krishna Talluri
    VP, Clinical & Medical Affairs

    Licensed physician with over 20 years of global clinical development and regulatory experience across all phases of development in multiple therapeutic areas with successful IND and NDA submissions. Trained at Duke University Medical Center and has worked in leadership roles at J&J, Talecris, PPD and Cato Research, in addition to clinical practice and patient management experience in India, the Caribbean and the US.

  • Default avatar
    Cynthia Pritchard
    VP, Regulatory & QA

    Over 30 years in the medical device/diagnostic/biologics industry. Strong Regulatory and Quality Assurance background, with extensive experience in FDA/ICH/ISO regulations, clinical project management, design control, and documentation, and over 40 successful submissions to the FDA and European regulatory agencies. Has a PhD in virology/molecular biology from Virginia Tech, and a Postdoctoral Fellowship from Harvard Medical School.

  • Default avatar
    Karl Leinsing
    VP, Development

    Over 20 years experience in medical device design and project management. Currently holds 19 patents (several patents pending), 5 design awards, and was listed as one of 100 notable people in the Medical Device Industry by MD&DI. He is a licensed professional engineer in New Hampshire and has conducted Medical Device and Manufacturing (MD&M) Seminars on The Science of Successful Product Design.


  • Default avatar
    Craig Colmar, Johnson and Colmar, 2201, Waukegan Road, Bannockburn, IL 60015
    Default avatar
    Michael Perkins, Perkins, Lund, COllar & Associates, 2607, Oberlin Road, Raleigh, NC 27608

Previous Investors

  • Default avatar
    Mardil Medical Devices Pvt. Ltd.